D Orazio & Associates Inc. Sells 321 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

D Orazio & Associates Inc. reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 52,069 shares of the healthcare conglomerate’s stock after selling 321 shares during the period. UnitedHealth Group accounts for about 4.1% of D Orazio & Associates Inc.’s investment portfolio, making the stock its 9th largest position. D Orazio & Associates Inc.’s holdings in UnitedHealth Group were worth $26,517,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Main Street Financial Solutions LLC lifted its holdings in shares of UnitedHealth Group by 8.1% during the 2nd quarter. Main Street Financial Solutions LLC now owns 4,514 shares of the healthcare conglomerate’s stock worth $2,299,000 after acquiring an additional 338 shares during the period. Vest Financial LLC lifted its holdings in shares of UnitedHealth Group by 0.9% during the 2nd quarter. Vest Financial LLC now owns 2,172 shares of the healthcare conglomerate’s stock worth $1,106,000 after acquiring an additional 19 shares during the period. Lansing Street Advisors raised its holdings in UnitedHealth Group by 7.2% in the second quarter. Lansing Street Advisors now owns 715 shares of the healthcare conglomerate’s stock valued at $364,000 after buying an additional 48 shares during the period. Private Wealth Partners LLC raised its holdings in UnitedHealth Group by 122.3% in the second quarter. Private Wealth Partners LLC now owns 2,147 shares of the healthcare conglomerate’s stock valued at $1,093,000 after buying an additional 1,181 shares during the period. Finally, Vanguard Capital Wealth Advisors raised its holdings in UnitedHealth Group by 1.0% in the second quarter. Vanguard Capital Wealth Advisors now owns 14,063 shares of the healthcare conglomerate’s stock valued at $7,162,000 after buying an additional 140 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $589.75 on Thursday. The company has a market cap of $542.80 billion, a PE ratio of 36.05, a P/E/G ratio of 1.66 and a beta of 0.58. The company has a fifty day moving average price of $564.99 and a two-hundred day moving average price of $516.56. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $607.94.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter in the previous year, the company posted $6.14 earnings per share. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. Research analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.42%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is 51.34%.

Insider Activity at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the topic of several research reports. Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price target for the company from $481.00 to $647.00 in a report on Wednesday, July 17th. Barclays lifted their price objective on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Wells Fargo & Company lifted their price objective on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Truist Financial lifted their price objective on shares of UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Finally, Baird R W upgraded shares of UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Two equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $614.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.